C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

To demonstrate a higher percent rate of achieved target lipid goals among patients at high cardiovascular risk using more potent lipid-lowering treatment options including high-potency statins and combination therapies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risk

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Baja, Hungary

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients at high cardiovascular risk according to Framingham or SCORE rates

Exclusion criteria

Not eligible for lipid or statin therapy
Intolerance to therapy
Patients at low or intermediate CV risk

Treatment and study plan

Primary outcomes

Percent rate of patients achieving target LDL cholesterol goals

Time frame: On each of the 3 visits performed during the study
Percent rate of patients achieving 50% or more reduction in LDL-cholesterol

Time frame: On each of the 3 visits performed during the study

Secondary outcomes

Percent rate of patients achieving target secondary (total Ch, triglycerides, HDL Ch) goals

Time frame: On each of the 3 visits performed during the study
Percent rate of compliance among patients in the study

Time frame: On each of the 3 visits performed during the study

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: C2 -CORVUS

Important dates

Study start: 2009
Study completion: 2009
First posted: Jun 16, 2009
Registry last updated: Dec 4, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed